Embryonic and genetic manipulation in fish

Fishes, the biggest and most diverse community in vertebrates are good experimental models for studies of cell and developmental biology by many favorable characteristics. Nuclear transplantation in fish has been thoroughly studied in China since 1960s. Fish nuclei of embryonic cells from different genera were transplanted into enucleated eggs generating nucleo-cytoplasmic hybrids of adults. Most importantly, nuclei of cultured goldfish kidney cells had been reprogrammed in enucleated eggs to support embryogenesis and ontogenesis of a fertile fish. This was the first case of cloned fish with somatic cells. Based on the technique of microinjection, recombinant MThGH gene has been transferred into fish eggs and the first batch of transgenic fish were produced in 1984. The behavior of foreign gene was characterized and the onset of the foreign gene replication occurred between the blastula to gastrula stages and random integration mainly occurred at later stages of embryogenesis. This eventually led to the transgenic mosaicism. The MThGH-transferred common carp enhanced growth rate by 2-4 times in the founder juveniles and doubled the body weight in the adults. The transgenic common carp were more efficient in utilizing dietary protein than the controls. An "all-fish" gene construct CAgcGH has been made by splicing the common carp beta-actin gene (CA) promoter onto the grass carp growth hormone gene (gcGH) coding sequence. The CAgcGH-transferred Yellow River Carp have also shown significantly fast-growth trait. Combination of techniques of fish cell culture, gene transformation with cultured cells and nuclear transplantation should be able to generate homogeneous strain of valuable transgenic fish to fulfil human requirement in 21(st) century.

Estradiol stimulates growth hormone production in female goldfish

The effects of estradiol (E(2)) on growth hormone (GH) production was investigated in gonad-intact female goldfish. It was first necessary to generate a specific antibody for use in immunocytochemistry, Western, and dot-blot analyses of GH production. To accomplish this, grass carp GH (gcGH) cDNA was cloned by the reverse transcription polymerase chain reaction (RT-PCR) and expressed in Echerichia coli and a specific polyclonal antibody to recombinant gcGH was generated in the rabbit. In Western blot, the anti-gcGH antibody specifically immunoreacted with recombinant gcGH, purified natural common carp GH, and with a single 21.5-kDa GH form from pituitary extracts of grass carp, common carp, goldfish, and zebrafish but not salmon, trout, or tilapia. Intraperitoneal injection of the recombinant gcGH enhanced the growth rates of juvenile common carp demonstrating biological activity of this GH preparation. Electron microscopic studies showed that the anti-gcGH-I antibody specifically reacted with GH localized in the secretory granules of the goldfish somatotroph. Using anti-gcGH-I in a dot-blot assay, it was found that in vivo implantation of solid silastic pellets containing E(2) (100 mu g/g body weight for 5 days) increased pituitary GH content by 150% in female goldfish. In a second, independent study employing a previously characterized anticommon carp GH antibody for radioimmunoassay, it was found that E(2) increased pituitary GH content by 170% and serum GH levels by approximately 350%. The E(2)-induced hypersecretion of GH and increase in pituitary GH levels was not associated with changes in steady-state pituitary GH mRNA levels, suggesting that this sex steroid may enhance GH synthesis at the posttranscriptional or translational level. Previous observations indicate that GH can stimulate ovarian E(2) production. The present results show that E(2) can in turn stimulate GH production, indicating the existence of a novel pituitary GH-ovarian feedback system in goldfish. (C) 1997 Academic Press.

HORMONAL REPLACEMENT THERAPY IN FISH - HUMAN GROWTH-HORMONE GENE-FUNCTION IN HYPOPHYSECTOMIZED CARP

Transgenic common carp, Cyprinus carpio, produced by the microinjection of fertilized eggs with a linearized chimeric plasmid pMThGH, a human growth hormone (hGH) gene with a mouse metallothionein-I (MT) gene promoter in pBR322, were used to produce F1 and F2 transgenics. Following hypophysectomy of the transgenic F2 common carp, non-transgenic common carp and non-transgenic crucian carp, growth was monitored for up to 110 days. In addition, recombinant hGH was injected subcutaenously into a group of the non-transgenic crucian carp. Growth rate analyses indicated that (1) hypophysectomy of non-transgenic common carp and crucian carp results in the cessation of growth, (2) hGH administration can stimulate the growth of hypophysectomized crucian carp and (3) hypophysectomized hGH-transgenic common carp continue to grow in the absence of their own growth hormone, suggesting that the hGH-transgene is being expressed in tissues other than the pituitary.

重组人内皮抑素的基因表达与表征

内皮抑素具有抑制内皮细胞增殖和抗肿瘤新生血管生成活性，在小鼠实验中对多种肿瘤取得了有效的结果，有望成为一种新型抗肿瘤药物。本论文从基因的获取到在大肠杆菌中的高效表达，系统地研究了重组内皮抑素的全过程，并对其体内、体外的生物学活性及多种光谱学性质进行了深入的研究。采用Trizol试剂改进法从人胚肝组织中制备细胞mR NA，通过RT-PCR方法获得人内皮抑素基因。应用基因工程技术构建了亚克隆载体和表达载体，在大肠杆菌BL21（DE3）中以包涵体方式表达出N-末端带有6XHisTag标签的融合蛋白，表达量最多达到菌体总蛋白的42％。建立了包涵体蛋白的复性和纯化方法，得到具有较高纯度的重组内皮抑素蛋白。首次用质谱法证实从大肠杆菌的包涵体中获得的重组蛋白，因宿主菌中水解甲硫氨酸的酶不能对所有包涵体蛋白起作用，而在目的蛋白中会棍有N-末端具有甲硫氨酸的产物。对内皮抑素基因做定点突变，首次将内皮抑素蛋白的N-末端锌离子结合位点的的His2、His4突变成Leu2、Va14，构建了点突变的亚克隆载体，为以后研究其作用机理提供了条件。重组内皮抑素能够抑制鸡胚尿囊膜血管生成和人脐静脉内皮细胞ECV-304的增殖，在小鼠体内实验中对黑色素瘤产生良好的抑瘤效果（P＜0.01）。通过细胞周期分析，首次发现重组内皮抑素在G2期抑制 ECV-304细胞的增殖。电镜观察发现受内皮抑素作用的ECV-304细胞，产生了凋亡小体并出现多种细胞凋亡特征。同时，首次发现内皮抑素能使Balb／c 3T3细胞产生凋亡。计算机结构模拟结果表明重组内皮抑素蛋白与天然蛋白具有相似的空间结构。研究了内皮抑素与锌离子、肝素、稀土离子作用后蛋白质的光谱学性质和二级结构的变化，首次发现偏酸性pH对肝素与内皮抑素的结合作用有特殊影响，为研究内皮抑素特异抑制肿瘤组织新生血管的生成提供了实验依据。从人胚肝组织出发初步完成了人硒蛋白P亚克隆载体的构建。

PAR4 和TFF2 在胃肠癌中的表达变异与临床关系以及 TFF2 的重组表达

胃癌和肠癌是常见的威胁人类健康的消化道恶性肿瘤，其发生发展涉及多因 子的作用及调控。其中，在胃肠道都有表达的蛋白酶激活受体（PARs）和三叶 因子蛋白（TFFs）家族都参与肿瘤发生发展的调控过程。正常生理条件下，PARs 的表达与胃肠道消化液的分泌和肌肉的收缩舒张相关。同时，在胃肠道肿瘤的发 生、浸润和转移过程中PARs和TFF2也发挥了作用。而PAR-4，除了具有凝血酶 激活后的血小板聚集功能外，还参与感染、细胞迁移和肿瘤的发生发展。在溃疡 性结肠炎，肠癌组织以及某些肠癌细胞系中都出现PAR4的异常表达，而这种异 常表达可能作为启动肠癌发生的重要环节。TFFs家族蛋白能够对抗粘膜损伤并 且参与修复以发挥保护胃肠道的功能。在肿瘤发生中，三叶因子既有报道作为肿 瘤抑制因子，又有报道作为潜在的肿瘤促进因子。含两个三叶因子结构域的 TFF2，主要表达在胃粘膜的颈细胞。在胃溃疡、慢性萎缩性胃炎及胃癌中，TFF2 的表达具有下降的趋势；而且分化程度越低的胃癌，TFF2的表达量越少，这是 因为TFF2的表达与胃粘膜细胞的增殖和恶性转移相关。在肠道，TFF2可以抑制 一氧化氮（NO）的生成以调节由NO引起的肠炎；在肠炎老鼠的模型中，TFF2 能减轻炎症和溃疡发生的程度，表明TFF2可能通过调节机体的免疫反应来抑制 肠道炎症的发生。 而本实验室前期对大蹼铃蟾皮肤分泌物中获得的新型血小板激动蛋白 -Bm-TFF2与PARs相互作用的实验，促使我们去研究人TFF2与PARs的关系。由 于免疫组化提示TFF2和PAR4在正常胃黏膜中都分布在从基底部到中间的位置， 而且TFF2第二个Loop区序列的保守性，以及和PAR4连接配体（tethered-ligand） 的高度相似性，促使我们推测PAR4和TFF2之间是否存在一种相互作用，或者 hTFF2是否能调节PAR4的生物学活性。所以该篇论文落脚于PAR4和hTFF2，着 重介绍PAR4和TFF2在胃肠道肿瘤中的表达变异以及TFF2对过表达PAR4的细胞 的趋化作用。 我们先用半定量PCR方法检测TFF2和PAR4在胃癌、肠癌及周围远癌部位组 织中mRNA的表达水平。结果提示两个基因在胃癌组织中的表达较周围远癌部位组织减弱，而在肠癌组织中的表达则较周围远癌部位组织增强。Western blotting 也得到相似的结果。为进一步明确PAR4和TFF2在胃癌和肠癌中表达的具体变化 情况，我们继而用实时荧光定量PCR对28例胃癌和38例肠癌及其周围远癌部位组 织中TFF2和PAR4的表达进行了研究。结果显示胃癌组织中两个基因mRNA的表 达都显著低于远癌部位组织（P<0.001），而肠癌组织中两个基因mRNA的表达 则显著高于远癌部位组织（P<0.001）。结合临床病理资料提示PAR4在淋巴结转 移的胃癌患者中的表达低于无淋巴结转移的患者（P<0.05），在胃窦癌中的表达 明显低于非胃窦癌（P<0.05）；而发生淋巴结转移的肠癌患者其TFF2和PAR4基 因的表达都显著高于无淋巴结转移的肠癌患者（P<0.05）；两个基因在中低分化 肠癌中的表达也显著高于高分化肠癌（P<0.001）。免疫组化结果也提示TFF2和 PAR4在胃癌中的表达显著低于周围远癌部位组织（P<0.001），而在肠癌中的表 达则显著高于周围远癌部位组织（P<0.001）。表明TFF2和PAR4在胃肠道肿瘤的 发生中可能受到某些因素的调节而协调性地一致性表达。 在细胞水平上，我们发现在同等浓度hTFF2的诱导下，过表达PAR4的Lovo 稳定株的细胞迁移能力较不表达者明显增强，并且hTFF2的促细胞迁移活性呈剂 量依赖性，同时伴随ERK1/2磷酸化的增强。同时，过表达PAR4的Lovo细胞增殖 能力强于无PAR4表达的细胞，但TFF2作用后其增强能力反而下降，表明TFF2 对过表达了PAR4的Lovo细胞具有抗增殖的能力。 总之这些结果提示PAR4和TFF2在胃肠道中协同表达的现实为两者之间产 生一定的作用提供了基础，而且这种共存为粘膜受损后的修复，组织自身平衡状 态的维持都发挥了一定的作用，同时也为临床相关疾病的诊断，治疗及预后提供 一个新的理论依据。当然，生理和病理情况下，存在于PAR4和TFF2之间的调控 和相互作用的分子机制仍不清楚，这也是进一步研究的关键所在。 为探讨其它动物体内三叶因子家族蛋白结构和功能的关系，我们进而利用原 核表达体系构建并表达纯化了Bm-TFF2以及它的两个单结构域。由于Bm-TFF2 分子中有三对二硫键，所以我们选用pET-32a表达体系表达融合的重组蛋白，并 利用融合蛋白N端引入的Xa因子酶切位点将融合蛋白中的硫氧还蛋白切除，亲和 柱及反向高压液相色谱纯化游离的重组蛋白。重组的Bm-TFF2全长具有血小板聚集活性，而第一个结构域只有诱导血小板变形的作用；三种重组蛋白都具有剂量 依赖性地诱导AGS细胞迁移的功能，但三种重组蛋白的细胞迁移活性无明显差 异。pET-32a表达体系成功表达Bm-TFF2的事实为我们研究人三叶因子家族蛋白 结构及功能关系提供一种方便而可靠的手段。

重组腺病毒载体vAd2tat 的构建及其在细胞中的表达

　目的　构建含HIV21 tat 基因重组腺病毒,观察在不同细胞中外源蛋白Tat 的表达,作为DC 抗HIV 疫苗的基 础。方法　通过PCR 扩增,获得HXB2 tat 的cDNA 片段,定向克隆入腺病毒转移载体pTrack2CMV ,线性化后转化含有腺病毒骨 架pAd2easy21 的大肠杆菌BJ5183 ,获得同源重组的质粒prAd2tat , Pac Ⅰ酶切纯化后转染293 细胞,包装成具有感染力的复制缺 陷型重组腺病毒vAd2tat 。结果　经PCR、酶切及DNA 序列测定,插入片段大小、方向正确,获得具有感染力的含有HIV21 tat 基 因的重组腺病毒;通过Western blot 方法检测,重组腺病毒在293 细胞中表达出Mr 为15 000 的蛋白。结论　成功构建了含有 HIV21 tat 基因的腺病毒,并观察到该基因在细胞中的表达。

HIV-1 C亚型gp120重组腺病毒载体的构建及gp120负载人树突状细胞疫苗的初步研究

获得性免疫缺陷综合征(AIDS)是一种由人类免疫缺陷病毒(HIV)引起的，以全身免疫系统受到严重损害为特征的传染性疾病。从目前HIV-1的流行趋势来看，HIV-1 C亚型已经成为全球最主要的流行株之一，因此，针对HIV-1 C亚型的疫苗设计颇为重要。gp120作为HIV-1的包膜糖蛋白，能够诱导广泛的中和抗体反应，中和进入机体的病毒粒子，阻止病毒早期感染，所以本实验选取HIV-1 C亚型密码子优化的gp120作为免疫原进行研究。目前的疫苗研究中，腺病毒载体是较理想的病毒载体之一，具有安全性好、外源基因容纳量大、感染效率高、操作简便等优点。我们以复制缺陷型腺病毒为载体，构建了表达HIV-1 C亚型密码子优化的gp120的重组腺病毒vAd-gp120，经Western Blot方法检测到了gp120蛋白的表达。树突状细胞（DC）是已知最强的抗原呈递细胞(APC)，也是目前发现的唯一能够刺激初始型T细胞增殖的细胞。经抗原致敏的DC可通过MHC-Ⅰ、MHC-Ⅱ途径递呈抗原，并激活T细胞，从而激发体内的体液免疫和特异性细胞免疫反应。我们利用Amaxa系统将HIV-1 C亚型gp120基因转入人外周血单核细胞来源的DC，构建了以DC为载体的治疗性疫苗，并对其功能进行初步研究，发现负载gp120的DC能够显著刺激淋巴细胞的增殖、增强CD8T细胞表面活化分子CD25的表达以及促进CD8T细胞分泌++IFN-γ，为下一步DC治疗性疫苗的体内研究奠定了基础。

Genetic analysis of all-fish growth hormone gene transferred carp (Cyprinus carpio L.) and its F-1 generation

Recombinant "all-fish" growth hormone gene (GH) was microinjected Into the fertilized eggs of carp. A comparison between the growth traits of transgenics and non-transgenics was carried out, and the transgenic individuals with significant "fast-growing" effect were successfully gained. A comparison on the reproductivities was also given out between the transgenics and their non-transgenic siblings, and showed that the reproductive capacity of transgenics was substantially equivalent to those of the non-transgenics. On the other hand, the genetic separation and the characteristic distribution of the F-1 generation were genetically analyzed, which gave solid evidence for the hypothesis that 2-3 chromosomes are integrated with transgene. In addition, the distinct biological effects for multisite-integrated transgenes were further discussed. The present study opens a door for the breeding of "fast-growing" transgenic fish.

抗黑色素瘤ScFv-超抗原SEA重组免疫毒素的构建与表达

提取鼠抗人黑色素瘤杂交瘤细胞株HB8759的总RNA，反转录成cDNA，用抗体可变区混合引物扩增出全套重、轻链可变区基因（VH、VLDNA），通过（Gly4Ser）3连接肤基因把VH和VL基因装配成单链抗体（ScFv）基因，将其克隆到噬菌粒载体pCANTABSE中，构建单链抗体噬菌体抗体库。用LIBr黑色素瘤细胞对抗体库进行了3轮亲合筛选。随机挑选克隆进行hage-ELISA鉴定，结果获得了2株具有较高ELISA活性的噬菌体单链抗体。序列测定证实得到的ScFv符合抗体可变区的结构特点，与已发表的鼠抗体可变区基因有较高的同源性。采用酶切连接和重叠PCR连接两种方法将抗黑色素瘤单链抗体基因和去除N端信号肤的金黄色葡萄球菌肠毒素A（SEA）基因进行融合，并将融合基因克隆于pET28-a表达载体的H招标签下游。SDS-PAGE分析表明，两种构建方法均表达了相对分子量约SOkD的蛋白条带，与预期目的蛋白分子量相符，主要以包涵体的形式存在，表达量占菌体蛋白的27％。将重组质粒在大肠杆菌中诱导表达，用盐酸肌溶解包涵体，Ni-NTA鳌合层析柱一步法纯化包涵体，再通过透析使目的蛋白复性。凝胶灰度扫描显示蛋白纯度达90％，凝胶电泳呈单一条带，蛋白量达0.47mg／mL。用健康人外周血单个核细胞作为效应细胞，LDH法检测ScFv-SEA融合蛋白对LiBr黑色素瘤细胞、MCF7乳腺癌的体外抑制率。结果表明该融合蛋白可以通过活化效应细胞，对表达相关抗原的肿瘤细胞产生有效的抗增殖作用，而对不表达该抗原的肿瘤细胞作用不显著。说明该融合蛋白赋予了SEA抗黑色素瘤特异性。以上实验结果为我们研究SEA对黑色素瘤的靶向杀伤作用奠定了可靠的实验基础。

两种抗HER2重组免疫毒素的构建与活性研究

HER2／neu基因在肿瘤中的过度表达使其成为许多肿瘤的标志分子。人肿瘤坏死因子（TNF-α）和肿瘤坏死因子相关的凋亡诱导配体（Trail）对肿瘤细胞的杀伤作用使其成为前景看好的抗肿瘤药物，对它们的细胞杀伤机制研究日渐深入。但临床研究发现HER2／neu过度表达的肿瘤细胞抵制TNF-α和Trail的肿瘤杀伤作用，因此经常产生耐药现象。为了增加过度表达HER2／neu的肿瘤细胞对TNF-a的敏感性和提高HER2／neu抗体的肿瘤杀伤效应，我们将抗HER2／neu人源化单链抗体scFvC6.5与人翔F-a融合，构建了免疫毒素scFvC6.5-TNF-α，完成了该重组蛋白在大肠杆菌中的表达，产率为800μg／L菌液。经过亲和层析和柱复性，融合蛋白的纯度达95％以上。ELISA试验表明scFvC6.5-TNF-a能够特异结合HER2／neu阳性卵巢癌细胞SKO从3和乳腺癌细胞MCF-7，而不结合HERZ／neu阴性的黑色素瘤细胞A-375。MTT试验表明scFvC6.5-TNF-a能够选择性的杀伤SKOV-3和MCF-7细胞，而不影响A-375细胞的生长。同时为了增加过度表达HER2／neu的肿瘤细胞对人可溶性肿瘤坏死因子相关的凋亡诱导配体（sTrail）的敏感性和提高HER2／neu抗体的肿瘤杀伤效应，我们构建了scFvC6．5与人sTrail的融合蛋白scFvC6.5-sTrail。重组子经酶切及测序证明序列正确后，在大肠杆菌BL21（DE3）中进行诱导表达。经SDS-PAGE及westem一blot鉴定，获得高水平包含体表达菌株，产率为700雌／L菌液。对表达产物进行变性、复性及纯化，SDS-PAGE结果显示纯度达95％以上。用ELISA法检测纯化后蛋白的结合活性表明融合蛋白scFvC6.5-sTrail能够特异结合HERZ／neu阳性卵巢癌细胞SKO从3、乳腺癌细胞McF-7和Trail敏感菌株MDA-MB-231，而不结合HER2／neu阴性和Trail受体阴性的黑色素瘤细胞A-375。MTT法检测其生物活性显示纯化后的scFvC6.5-sTrail蛋白对SKO从3、MCF-7、MDA-MB-231均具有细胞毒活性，并存在剂量依赖性，但对A-375细胞没有作用。细胞凋亡流式分析表明这两种免疫毒素对SKO从3靶细胞的杀伤作用是通过诱导细胞凋亡所致。提示这两种免疫毒素在抗肿瘤靶向治疗中具有潜在的应用价值。

Vc“二步发酵法”最佳组合生产菌系的选育及其“工程菌”的构建

对24株不同组合的Vc“二步发酵法”生产菌系中筛选出了最佳组合生产菌系H_(19)S_(19)。对该菌系的形态学及生理生化特性的研究表明，H_(19)为地衣芽孢杆菌，S_(19)的分类地位目前还难以确定，但与尹光琳等报道的氧化葡萄糖酸杆菌相比，具有许多新的不同特点。用单亲本灭活的原生质体融合技术进行了H_(19)和S_(19)以及132及S_(19)的原生质体融合，共获得400株重组子，其中有2株产生2--酮基--L--古龙酸产量高且稳定性好的重组子。其中一株是由H_(19)和S_(19)原生质体以H_(19)为背景融合产生的，另一侏是132和S_(19)原生质体以S_(19)为背景产生的。

利福霉素发酵中失活因子作用实质及高产工程菌构建研究

本文报导了实验中发现能大幅度破坏利福霉素（Rif sv）抗菌活性的物质，称其为失活因子。此失活因子经分离提纯后实验结果确证其本质是利福霉素胞外生物降解酶。实验表明失活因子活性受发酵中存在着一种抗生素另一种小分子物质的调控证实了抗生素发酵中存在着一种抗生素降解代谢途径和抗菌降解机制。从而进一步提出了菌株产生抗生素降解水平是由以往抗生素合成机制。抗性机制和作者等人提出的抗生素降解失活机制三者共同决定的新概念，并使高产工程菌株构建获得成功。

无指盘臭蛙皮肤抗菌肽Odorgrin A和Odorgrin C基因表达载体的构建及其在毕赤酵母中的表达

研究背景与目的：近二十年来，抗生素的广泛使用以及一些不当应用导致临床上出现大量的耐药性病原菌，所以不易产生耐药性的抗菌肽就成为目前研究的热点。本课题组此前的研究表明无指盘臭蛙（Odorrana grahami）皮肤抗菌肽具有广谱抗菌活性，但对真核细胞没有毒性，因此有成为新型药物的潜力。本研究采用毕赤酵母真核表达系统来生物合成抗菌肽Odorgrin A和Odorgrin C，为大量获取抗菌肽资源提供技术支撑。 方法：依照Odorgrin A和C的氨基酸序列、采用酵母偏爱密码子分别设计并化学合成了相应的目的基因序列。目的片段从合成质粒上用Xho Ι和EcoR Ι双酶切下后，与经同样限制酶完全酶切pPIC9K载体所获得的两个大片段直接连接，并转化至大肠杆菌DH5α。用PCR扩增、酶切及测序检测，鉴定正确的重组质粒。提取大量表达载体pPIC9K - Odo A和C并使之线性化后经电击法分别转化毕赤酵母（Pichia pastoris）GS115宿主菌，用营养缺陷型筛选、遗传霉素抗性筛选、PCR扩增和测序检测，鉴定并筛选出对G418具高抗性的Odorgrin A和C重组酵母菌。用甲醇对之进行诱导表达，SDS - PAGE电泳及反相层析检测表达产物，并做抑菌活性检测。 成果：PCR扩增、酶切及测序等结果表明表达载体pPIC9K - Odo A和C构建成功。营养缺陷型筛选、遗传霉素抗性筛选、PCR扩增和测序等证实pPIC9K - Odo A和C已整合入酵母基因组中。SDS - PAGE电泳及反相层析结果表明抗菌肽Odorgrin A和C成功地获得了分泌表达。而抑菌活性实验则检测到部分阳性克隆菌诱导分泌表达的抗菌肽Odorgrin A和C都对测试菌的生长具有较高（>94%）的抑制率。 结论：无指盘臭蛙皮肤抗菌肽Odorgrin A和Odorgrin C基因的表达载体都构建成功，并且都在毕赤酵母系统中获得了成功表达。 Background ＆ Objective: In the recent twenty years, a lot of pathogenic bacteria have come forth in clinic with durable trait derived from making use of and abusing the traditional antibiotics. Therefore, studying antimicrobial peptides, not be easy to be invalidated by durable bacteria, are becomimg popular and important. The skin antimicrobial peptides of Odorrana grahami with broad spectrum antibacterial activity and no toxicity to eukaryotic cell, discovered by previous research work of our workgroup, are looked forward to being potential medication. Pichia pastoris expressional system was used for biosynthesis antimicrobial peptides Odorgrin A and Odorgrin C in this study, for producing abundant antimicrobial peptides. Methods: The foreign fragments which included Odorgrin A or Odorgrin C gene according to their amino acid sequence respectively were synthesized based on the biased codon usage of yeast. The DNA fragments, obtained from the plasmids containing them by digested with Xho Ι and EcoR Ι, were directly ligated with the two bigger fragments obtained from the vector pPIC9K by digested with the same restriction enzymes. And then they were transformed into Escherichia coli DH5α to be selected and amplified positive colonies. The recombinants were testified by using PCR amplification, enzymes digestion and sequencing of the foreign fragment. After the expressional vector pPIC9K - Odo A and pPIC9K - Odo C were linearized, they were transformed into Pichia pastoris GS115 strain by the electroporation. Then the positive colonies which were of the highest geneticin resistant were selected through auxotrophic screening, genetic resistant screening, PCR amplification and sequencing of the inserted fragment. Methanol was used to induce the recombinant yeasts to express the foreign gene. SDS-PAGE electrophoresis, reversed phase chromatography and antibacterial activity experiment were used to testify the expressional products. Results: The evidences of PCR, enzymes digestion and sequence analysis confirmed that the expressional vector pPIC9K - Odo A and pPIC9K - Odo C have been constructed correctly. The results of auxotrophic screening, of genetic resistant screening, of PCR and sequencing of the foreign fragment showed that Odorgrin A and Odorgrin C gene have been homologous integrated with the Pichia pastoris genome. And it was also testified that antimicrobial peptides Odorgrin A and Odorgrin C have been expressed successfully by using SDS - PAGE electrophoresis, reversed phase chromatography and antibacterial activity experiment. Conclusion: The expressional vector of the skin antimicrobial peptides Odorgrin A and Odorgrin C gene of Odorrana grahami have been constructed correctly and both of the genes have been expressed successfully in Pichia pastoris system in this study.

小麦抗白粉病新基因PmCD1和抗条锈病基因YrCD的鉴定及分子标记筛选

本研究对自育小麦白粉病抗源“07鉴126”和条锈病抗源CD1437、CD0534-5进行抗性遗传分析和微卫星引物的筛选，建立了与PmCD1和YrCD抗病基因连锁的SSR分子标记，主要研究结果如下： 1.小麦白粉抗源“07鉴126”抗白粉病基因的鉴定和分子标记的建立 品系“07鉴126”对我国目前白粉菌强优势生理小种E09、E11和其它多种小种表现免疫或高度抵抗。Pm-sus是07鉴126的自然突变感病株。利用“07鉴126”和Pm-sus的F2抗病性分离群体进行抗条锈病性遗传分析和分子标记定位，结果表明，“07鉴126”的白粉抗性为显性单基因控制的全生育期抗性，暂命名为PmCD1；并筛选到了与PmCD1共分离的显性SSR分子标记Xbarc183。系谱分析和分子标记分析表明PmCD1来源于荆州黑麦。抗谱分析表明PmCD1不同于已知的黑麦抗白粉基因，是一个新的抗白粉病基因。Xbarc183这一分子标记的建立为PmCD1的分子标记辅助选择和抗病基因累加提供了方便。 2.小麦条锈抗源CD1437抗条锈病基因的鉴定和分子标记的建立 利用对优势条锈菌小种条中32免疫的小麦品系CD1437及其自然突变感病株Yr-sus杂交构建F2、F3抗病性分离群体。抗条锈病性遗传分析结果显示，1437的抗条锈性为显性单基因控制的全生育期抗性，该基因暂命名为YrCD。SSR分析发现，位于1B染色体上的7个SSR标记Xcfd65、Xgwm11、Xgwm18、Xbarc187、Xwmc406、 Xwmc419、Xwmc216依次分布在YrCD的一侧，与YrCD的遗传距离在1.7 cM至9.2 cM。YrCD和YrCH42的等位性分析显示二者可能为等位基因。YrCD和Yr24、Yr26的抗谱相似。系谱分析和分子标记分析表明贵农20是YrCD的供体。本研究推测YrCD、Yr24、Yr26和YrCH42可能是等位基因，并推测Yr-sus是缺失突变体。 3. 小麦条锈抗源CD0534-5抗条锈病基因的鉴定 利用对条中32免疫的小麦抗条锈病品系CD0534-5及其感病重组自交系CD0534-4建立F2抗病性分离群体。抗条锈病性遗传分析表明，CD0534-5的条锈抗性由两对独立的显性主效基因控制。用BSK法分析，发现其中一对基因与SSR分子标记Xgwm11、Xgwm18、Xwmc128、Xwmc419连锁，该基因是来源于贵农20的YrCD。另一抗性基因来源贵农19，是极有利用价值的未知抗性基因。 This study focused on the investigation and identification of a novel powdery mildew resistant gene PmCD1 in wheat lines 07jian126 and stripe rust resistant gene YrCD in wheat lines CD1482 and CD0534-5, and screened SSR markers tightly linked to them. The main results were as follows: 1.Identification and SSR markers screening of a novel powdery mildew PmCD1 in wheat line 07jian126. Using a Pm resistant wheat line 07jian126 and its Pm susceptible mutant, a F2 population was constructed. Pedigree and genetic analyses indicated that the Pm resistance in 07jian126 was tranderred from rye (Secale cereale L.) cv. Jinzhou and was controlled by a single dominant gene. Differential test using 21 Bgt isolates revealed that the Pm resistant gene in 07jian126 is novel and was temporarily designated as PmCD1. A dominant SSR marker Xbarc183/130 bp was found co-segregated with PmCD1 in the F2 population. The diagnostic band of Xbarc183/130 bp co-segregating with PmCD1 could be used as an ideal marker in marker-assisted-selection during wheat breeding program. 2. Identification and SSR markers mapping of yellow rust resistant gene YrCD in wheat line CD1437. Wheat line CD1437 was highly resistant to predominant Chinese stripe rust race CYR32 at both seedling and adult stages. A F2 population was developed from the cross of CD1437 and its Yr susceptible mutant Yr-sus. Genetic analysis indicated line CD1437 contains a single dominant gene, temporarily designated YrCD. Seven SSR markers on the chromosome 1BS including Xcfd65, Xgwm11, Xgwm18, Xbarc187, wmc406, Xwmc419and Xwmc216 were close linked to YrCD with a genetic dsitance 1.7 cM to 9.2 cM. YrCD came from wheat cultivar Guinong 20. Allelic test of CD1437 and Chinese cultivar Chuanmai 42 indicated that YrCD and YrCH42 were allelic. Reaction patterns of YrCD and Yr24, Yr26 to 21 PST isolates were the same. These results suggested that YrCD and Yr24, Yr26, YrCH42 might be allelic. 3.Detection and identification of yellow rust resistance genes in wheat line CD0534-5 Wheat line CD0534-5 was highly resistant to predominant Chinese stripe rust race CYR32, while its recombinant inbred line CD0534-4 was susceptible. Genetic analysis with a F2 population developed from the cross of CD0534-5 and CD0534-4 indicated line CD0534-5 contains two independent dominant genes. Four SSR markers on the chromosome 1BS including Xgwm11, Xgwm18, Xwmc128, Xwmc419 were found to linked with one gene in CD0534-5. According the locations of makers and pedigree, this gene in CD0534-5 was YrCD, from cultivar Guinong 20. Another resistant gene was from cultivar Guinong 19, different with those genes on 1B such as Yr10, Yr15, Yr5 etc, was a valuable resistant gene in wheat breeding.